News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘ChildhoodCancer’ clear

  • Dana-Farber/Boston Children's researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated in an international clinical study of a new form of gene therapy.

Tags: ChildhoodCancer, ImmuneSystem, Genetics, Leukemia

  • New research shows that although women who survived childhood cancer face an increased risk of infertility, nearly two-thirds of those who tried unsuccessfully to become pregnant for at least a year eventually conceived.

Tags: ChildhoodCancer, Survivorship

  • A type of low-grade but sometimes lethal brain tumor in children has been found to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors.

Tags: ChildhoodCancer, BrainTumors

  • When the eye cancer retinoblastoma is diagnosed in racial and ethnic minority children whose families don't have private health insurance, it often takes a more invasive course than in other children, probably because of delays in diagnosis, according to researchers at Dana-Farber/Children's Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, Disparities

  • Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, StemCellTransplant

  • An irregularity within many neuroblastoma cells may indicate whether the tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.

Tags: ChildhoodCancer

  • Dana-Farber/Children's Hospital Cancer Center is one of the first three institutions to be named as a Center of Excellence by Alex's Lemonade Stand Foundation.

Tags: ChildhoodCancer, Grants, Honors

  • Stuart H. Orkin, MD, chairman of the department of pediatric oncology at Dana-Farber/Children’s Hospital Cancer Center, will receive the Jessie Stevenson Kovalenko Medal at the National Academy of Sciences’ 150th Annual meeting in April.

Tags: ChildhoodCancer, Honors

  • A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

  • Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.

Tags: chemotherapy, ChildhoodCancer, Leukemia

Showing 11-20 of 40 items